CTSB and hepatocellular carcinoma: Clinically, our data demonstrated that in HCC patients, elevated CTSB expression correlated with worse overall survival and increased cancer progression (Fig. 4i, k and Supplementary Fig. 4j), but its expression was not correlated with tumor size (Fig. 4l).